New Zealand markets close in 1 hour 57 minutes

China Petroleum & Chemical Corporation (0386.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
3.720+0.060 (+1.64%)
As of 10:48AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 549.63B
Enterprise value 765.26B
Trailing P/E 5.00
Forward P/E 5.63
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.13
Price/book (mrq)0.48
Enterprise value/revenue 0.26
Enterprise value/EBITDA 3.16

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 30.83%
S&P500 52-week change 3-5.84%
52-week high 34.280
52-week low 33.250
50-day moving average 33.591
200-day moving average 33.785

Share statistics

Avg vol (3-month) 399.75M
Avg vol (10-day) 360.07M
Shares outstanding 525.51B
Implied shares outstanding 6N/A
Float 837.32B
% held by insiders 10.00%
% held by institutions 134.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.71
Forward annual dividend yield 419.36%
Trailing annual dividend rate 30.47
Trailing annual dividend yield 312.84%
5-year average dividend yield 48.60
Payout ratio 446.24%
Dividend date 3N/A
Ex-dividend date 431 May 2022
Last split factor 213:10
Last split date 310 Jun 2013

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022

Profitability

Profit margin 2.58%
Operating margin (ttm)4.09%

Management effectiveness

Return on assets (ttm)3.93%
Return on equity (ttm)9.60%

Income statement

Revenue (ttm)2.93T
Revenue per share (ttm)24.25
Quarterly revenue growth (yoy)33.80%
Gross profit (ttm)519.81B
EBITDA 224.71B
Net income avi to common (ttm)75.77B
Diluted EPS (ttm)0.730
Quarterly earnings growth (yoy)24.30%

Balance sheet

Total cash (mrq)188.32B
Total cash per share (mrq)1.55
Total debt (mrq)381.46B
Total debt/equity (mrq)40.80
Current ratio (mrq)0.93
Book value per share (mrq)6.55

Cash flow statement

Operating cash flow (ttm)193.58B
Levered free cash flow (ttm)26.77B